• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非精氨酸介导的 Anti-E6 ShRNA 递呈抑制 Hela 细胞体外生长。

Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitro.

机构信息

Department of Molecular Virology, Pasteur Institute of Iran, Tehran 1316943551, Iran.

Department of Microbiology, School of Biology, College of Science, University of Tehran, 1417614411, Iran.

出版信息

Iran Biomed J. 2023 Nov 1;27(6):349-56. doi: 10.61186/ibj.3963.

DOI:10.61186/ibj.3963
PMID:37978985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10826911/
Abstract

BACKGROUND

The E6 oncoprotein of HPV plays a crucial role in promoting cell proliferation and inhibiting apoptosis, leading to tumor growth. Non-viral vectors such as nona-arginine (R9) peptides have shown to be potential as carriers for therapeutic molecules. This study aimed to investigate the efficacy of nona-arginine in delivering E6 shRNA and suppressing the E6 gene of HeLa cells in vitro.

METHODS

HeLa cells carrying E6 gene were treated with a complex of nona-arginine and E6 shRNA. The complex was evaluated using gel retardation assay and FESEM microscopy. The optimal N/P ratio for R9 peptide to transfect HeLa cells with luciferase gene was determined. Relative real-time PCR was used to evaluate the efficiency of mRNA suppression efficiency for E6 shRNA, while the effect of E6 shRNA on cell viability was measured using an MTT assay.

RESULTS

The results indicated that R9 efficiently binds to shRNA and effectively transfects E6 shRNA complexes at N/P ratios greater than 30. Transfection with R9 and PEI complexes resulted in a significant toxicity compared to the scrambled plasmid, indicating selective toxicity for HeLa cells. Real-time PCR confirmed the reduction of E6 mRNA expression levels in the cells transfected with anti-E6 shRNA.

CONCLUSION

The study suggests that R9 is a promising non-viral gene carrier for transfecting E6 shRNA in vitro, with significant transfection efficiency and minimal toxicity.

摘要

背景

HPV 的 E6 癌蛋白在促进细胞增殖和抑制细胞凋亡方面发挥着关键作用,导致肿瘤生长。非病毒载体,如九聚精氨酸(R9)肽,已被证明是治疗分子载体的潜在选择。本研究旨在研究九聚精氨酸在递送 E6 shRNA 和体外抑制 HeLa 细胞中 E6 基因方面的功效。

方法

用携带 E6 基因的 HeLa 细胞处理非病毒载体 R9 肽和 E6 shRNA 的复合物。通过凝胶阻滞试验和 FESEM 显微镜评估复合物。确定 R9 肽转染 HeLa 细胞携带荧光素酶基因的最佳 N/P 比。使用相对实时 PCR 评估 E6 shRNA 的 mRNA 抑制效率,同时使用 MTT 测定 E6 shRNA 对细胞活力的影响。

结果

结果表明,R9 能够有效地结合 shRNA,并在 N/P 比大于 30 时有效地转染 E6 shRNA 复合物。与对照质粒相比,R9 和 PEI 复合物的转染导致明显的毒性,表明对 HeLa 细胞具有选择性毒性。实时 PCR 证实了转染抗 E6 shRNA 的细胞中 E6 mRNA 表达水平的降低。

结论

该研究表明,R9 是一种很有前途的非病毒基因载体,可用于体外转染 E6 shRNA,具有显著的转染效率和最小的毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/375b16d8e0c2/ibj-27-349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/1f5649803863/ibj-27-349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/8d38b579cc3c/ibj-27-349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/2e2206b134de/ibj-27-349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/375b16d8e0c2/ibj-27-349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/1f5649803863/ibj-27-349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/8d38b579cc3c/ibj-27-349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/2e2206b134de/ibj-27-349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef9e/10826911/375b16d8e0c2/ibj-27-349-g004.jpg

相似文献

1
Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitro.非精氨酸介导的 Anti-E6 ShRNA 递呈抑制 Hela 细胞体外生长。
Iran Biomed J. 2023 Nov 1;27(6):349-56. doi: 10.61186/ibj.3963.
2
Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.用慢病毒载体递送靶向人乳头瘤病毒E6和E7癌基因的短发夹RNA在体外和体内抑制宫颈癌细胞生长。
Cancer Gene Ther. 2006 Nov;13(11):1023-32. doi: 10.1038/sj.cgt.7700971. Epub 2006 Jun 30.
3
Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.用人乳头瘤病毒癌蛋白短发夹RNA包装的人乳头瘤病毒样颗粒对宫颈癌细胞生长的抑制作用
Mol Cancer Ther. 2009 Feb;8(2):357-65. doi: 10.1158/1535-7163.MCT-08-0626. Epub 2009 Jan 27.
4
Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells.人乳头瘤病毒16型E6特异性短发夹RNA对宫颈癌细胞的延长效应
Int J Gynecol Cancer. 2006 Mar-Apr;16(2):718-29. doi: 10.1111/j.1525-1438.2006.00380.x.
5
Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.RNA干扰在体外和体内对人乳头瘤病毒16型E6癌基因表达的抑制作用
Int J Gynecol Cancer. 2006 Mar-Apr;16(2):743-51. doi: 10.1111/j.1525-1438.2006.00384.x.
6
[Inhibitory effects of human papilloma virus 18 E6 gene in HeLa cell transfected with shRNA].[人乳头瘤病毒18型E6基因在转染shRNA的HeLa细胞中的抑制作用]
Zhonghua Fu Chan Ke Za Zhi. 2005 Oct;40(10):693-6.
7
[Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].[针对人乳头瘤病毒18 E6/E7的反义核酸靶向作用对人宫颈癌增殖和凋亡的影响:HeLa细胞的体外实验]
Zhonghua Yi Xue Za Zhi. 2007 Jun 19;87(23):1618-21.
8
Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 E6 silencing RNA.微阵列分析鉴定由人乳头瘤病毒18型E6沉默RNA诱导的差异表达基因。
Int J Gynecol Cancer. 2009 May;19(4):547-63. doi: 10.1111/IGC.0b013e3181a44c68.
9
[Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki].[RNA干扰对宫颈癌CaSki细胞系中HPV16 E6癌基因表达的抑制作用]
Ai Zheng. 2004 Nov;23(11):1257-62.
10
Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.HPV16E6/E7 的转录基因沉默通过体外和体内的细胞凋亡诱导生长抑制。
Gynecol Oncol. 2012 Feb;124(2):296-302. doi: 10.1016/j.ygyno.2011.10.028. Epub 2011 Nov 3.

引用本文的文献

1
Central position of histidine in the sequence of designed alternating polarity peptides enhances pH-responsive assembly with DNA.组氨酸在设计的交替极性肽序列中的中心位置增强了与DNA的pH响应组装。
BMC Biotechnol. 2025 Jul 1;25(1):54. doi: 10.1186/s12896-025-00976-4.

本文引用的文献

1
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.2020 年全球宫颈癌发病率和死亡率估计:世卫组织全球消除宫颈癌倡议的基线分析。
Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.
2
Gene knock-out chain reaction enables high disruption efficiency of HPV18 / genes in cervical cancer cells.基因敲除连锁反应可实现人乳头瘤病毒18型/基因在宫颈癌细胞中的高破坏效率。
Mol Ther Oncolytics. 2021 Dec 18;24:171-179. doi: 10.1016/j.omto.2021.12.011. eCollection 2022 Mar 17.
3
Extension in the approaches to treat cancer through siRNA system: a beacon of hope in cancer therapy.
通过 siRNA 系统治疗癌症方法的扩展:癌症治疗的希望之光。
Drug Deliv Transl Res. 2022 May;12(5):1002-1016. doi: 10.1007/s13346-021-00995-6. Epub 2021 May 10.
4
Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives.纳米颗粒介导的协同化免疫化疗用于定制癌症治疗:最新进展与展望。
J Nanobiotechnology. 2021 Apr 17;19(1):110. doi: 10.1186/s12951-021-00861-0.
5
The Development of Functional Non-Viral Vectors for Gene Delivery.功能性非病毒基因载体的开发。
Int J Mol Sci. 2019 Nov 4;20(21):5491. doi: 10.3390/ijms20215491.
6
Gene delivery by peptide-assisted transport.通过肽辅助转运进行基因递送。
Curr Opin Biomed Eng. 2018 Sep;7:71-82. doi: 10.1016/j.cobme.2018.10.002. Epub 2018 Oct 9.
7
Versatility of cell-penetrating peptides for intracellular delivery of siRNA.细胞穿透肽在 siRNA 细胞内递送中的多功能性。
Drug Deliv. 2018 Nov;25(1):1996-2006. doi: 10.1080/10717544.2018.1543366.
8
Synthetic siRNA targeting human papillomavirus 16 E6: a perspective on in vitro nanotherapeutic approaches.靶向人乳头瘤病毒 16 E6 的合成 siRNA:体外纳米治疗方法的展望。
Nanomedicine (Lond). 2018 Feb 1;13(4):455-474. doi: 10.2217/nnm-2017-0242. Epub 2018 Jan 31.
9
Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.中国台州地区人乳头瘤病毒(HPV)18基因变异与宫颈癌风险
Gene. 2018 Mar 20;647:192-197. doi: 10.1016/j.gene.2018.01.037. Epub 2018 Jan 10.
10
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets.HPV E6/E7 致癌基因:病毒致癌的关键因素和治疗靶点。
Trends Microbiol. 2018 Feb;26(2):158-168. doi: 10.1016/j.tim.2017.07.007. Epub 2017 Aug 17.